Physician

Raghuveer Annam, M.D.

According to 2025 Medicare claims, Raghuveer Annam, M.D. (NPI: 1386735850) practices internal medicine in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Warren, NJ. This provider's primary affiliated billing organization is ST. LUKE'S WARREN PHYSICIAN GROUP, PC (NPI: 1922740422; TIN: 223837316) and primary practice location at 08865-2774. Annam is affiliated with the St. Luke's Medicare ACO (ACO ID: A3560), participating under the MSSP model.

Annam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 244 traditional Medicare patients, billed 2,152 HCPCS/CPT codes, and received $160,835 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,683 prescription claims across 394 beneficiaries totaling $618,936 in drug costs, led by Eliquis (Apixaban). DME data shows 75 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $324,638 to $160,835. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $10,385 to $5,717.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	457	4,817	$324,638
2016	485	4,871	$342,866
2017	405	4,237	$287,720
2018	397	4,281	$289,269
2019	386	3,716	$260,457
2020	302	2,776	$190,050
2021	277	2,600	$209,887
2022	253	1,812	$155,319
2023	227	1,464	$133,366
2024	244	2,152	$160,835

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	374	12,459	$722,195
2016	394	12,409	$712,079
2017	401	11,468	$621,051
2018	379	11,985	$660,922
2019	370	11,284	$676,721
2020	365	9,740	$657,057
2021	368	7,962	$638,805
2022	377	7,330	$677,955
2023	348	6,388	$687,100
2024	394	6,683	$618,936

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	160	720	$16,433
2016	170	572	$11,266
2017	93	471	$8,350
2018	69	421	$7,336
2019	61	318	$4,959
2020	38	213	$2,336
2021	15	118	$1,557
2022	14	83	$1,337
2023	11	90	$1,197
2024	N/R	75	$2,862

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	155	155	$150
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	226	800	$98
90662	Influenza vaccine split virus, preservative free	99	99	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	163	233	$73
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	212	596	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	79	4,484	$85,226
Jardiance	Empagliflozin	75	4,470	$82,286
Farxiga	Dapagliflozin Propanediol	63	3,347	$62,653
Januvia	Sitagliptin Phosphate	22	1,980	$34,657
Ozempic	Semaglutide	18	868	$28,101

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	20	$1,493
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$754
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	20	$435
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$168
A4259	Lancets, per box of 100	N	N/R	11	$13

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Raghuveer Annam, M.D.?

Tedicare shows public-source Medicare data for Raghuveer Annam, M.D. (NPI 1386735850), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Raghuveer Annam, M.D. have ACO affiliation data?

Raghuveer Annam, M.D. is shown with ACO affiliation data for St. Luke's Medicare ACO (MSSP, ACO ID A3560).

What billing organization is linked to Raghuveer Annam, M.D.?

Raghuveer Annam, M.D. is linked to ST. LUKE'S WARREN PHYSICIAN GROUP, PC (billing NPI 1922740422) in the available physician profile data.

Does Raghuveer Annam, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.